Rubio, Terrence L.

HRN: 21-84-25  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2022
CEFTRIAXONE 1G (VIAL)
08/25/2022
09/01/2022
IVTT
860mg
OD
ATP; PCAP
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaEye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: